Expertise in
12
conditions

Dr. Meghan E. Sise

Nephrology
Massachusetts General Hospital-Renal Associates
165 Cambridge St Ste 302, 
Boston, MA 
Accepting New Patients
Offers Telehealth
17 Years of Experience
Expertise in
12
conditions
Massachusetts General Hospital-Renal Associates
165 Cambridge St Ste 302, 
Boston, MA 

Overview

Meghan Sise is a Nephrologist practicing medicine in Boston, Massachusetts. She has been practicing medicine for over 17 years.

Dr. Sise is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Interstitial Nephritis, Chronic Kidney Disease, Prerenal Azotemia, Pseudohypoaldosteronism Type 2, and Kidney Transplant.

She is actively involved in clinical research, co-authoring 162 peer reviewed articles and participating in 6 clinical trials. Dr. Sise is currently accepting new patients.

Graduate Year

2009

Specialties

Nephrology

Licenses

Internal Medicine in MA

Hospital Affiliations

Newton-Wellesley Hospital
Massachusetts General Hospital
North Shore Medical Center -
Brigham And Women's Hospital
Wentworth-Douglass Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Massachusetts General Hospital-Renal Associates
165 Cambridge St Ste 302, Boston, MA 02114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
Enrollment Status: Terminated
Publish Date: December 03, 2024
Intervention Type: Drug
Study Drugs: Glecaprevir, Pibrentasvir
Study Phase: Phase 4
A Multi-Center, Open-Label Study of Glecaprevir/Pibrentasvir to Treat Recipients of Transplanted Kidneys From Deceased Donors With Hepatitis C Virus
A Multi-Center, Open-Label Study of Glecaprevir/Pibrentasvir to Treat Recipients of Transplanted Kidneys From Deceased Donors With Hepatitis C Virus
Enrollment Status: Completed
Publish Date: January 26, 2022
Intervention Type: Drug
Study Drug: Glecaprevir/pibrentasvir treatment
Study Phase: Phase 4
Safety, Efficacy, and Changes in Traditional and Novel Biomarkers of Kidney Function in Patients With Hepatitis C and Advanced Chronic Kidney Disease Treated With Abbvie Viekira Pak or Mavyret Regimen
Safety, Efficacy, and Changes in Traditional and Novel Biomarkers of Kidney Function in Patients With Hepatitis C and Advanced Chronic Kidney Disease Treated With Abbvie Viekira Pak or Mavyret Regimen
Enrollment Status: Completed
Publish Date: November 05, 2021
Intervention Type: Drug
Study Drugs: Viekira Pak ± Ribavirin, Mavyret
Study Phase: Phase 4
A Proof of Concept Study of Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
A Proof of Concept Study of Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
Enrollment Status: Completed
Publish Date: June 09, 2020
Intervention Type: Drug
Study Phase: Phase 4
Effect of Ledipasvir and Sofosbuvir on Proteinuria and Estimated Glomerular Filtration Rate in Patients With Early Stage (1-3) Hepatitis C Associated Chronic Kidney Disease
Effect of Ledipasvir and Sofosbuvir on Proteinuria and Estimated Glomerular Filtration Rate in Patients With Early Stage (1-3) Hepatitis C Associated Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: January 13, 2020
Intervention Type: Drug
Study Phase: Not Applicable
Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
Enrollment Status: Withdrawn
Publish Date: June 03, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

162 Total Publications

Early treatment with rasburicase and risk of kidney replacement therapy and death in adults with tumour lysis syndrome: emulated target trial.
Early treatment with rasburicase and risk of kidney replacement therapy and death in adults with tumour lysis syndrome: emulated target trial.
Journal: BMJ (Clinical research ed.)
Published: July 23, 2026
Similar Doctors
Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Melrosewakefield Healthcare Inc.

170 Governors Ave, 
Medford, MA 
 (4.9 miles away)
781-979-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sagar Nigwekar is a Nephrologist practicing medicine in Medford, Massachusetts. Dr. Nigwekar is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Calciphylaxis, Calcinosis, Chronic Kidney Disease, Parathyroidectomy, and Kidney Transplant. Dr. Nigwekar is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Office

101 Merrimac St Ste 1, 
Boston, MA 
 (0.1 miles away)
617-726-1108
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Niles is a Nephrologist practicing medicine in Boston, Massachusetts. Dr. Niles is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Glomerulonephritis, Granulomatosis with Polyangiitis, Lupus Nephritis, and Minimal Change Disease. Dr. Niles is currently accepting new patients.

Expertise in
6
conditions
Expertise in
6
conditions
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (0.1 miles away)
617-726-5050
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Allegretti is a Nephrologist practicing medicine in Boston, Massachusetts. Dr. Allegretti is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Hepatorenal Syndrome, Acute Tubular Necrosis, Fanconi Syndrome, and Fanconi Bickel Syndrome. Dr. Allegretti is currently accepting new patients.

Frequently Asked Questions about Dr. Meghan E. Sise

How do I make an appointment with Dr. Meghan E. Sise?

You can book an appointment with Dr. Meghan E. Sise by calling their office at 617-726-5050. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Meghan E. Sise a top-rated expert for Interstitial Nephritis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meghan E. Sise is classified as an Elite expert for Interstitial Nephritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Meghan E. Sise specialize in?

While Dr. Meghan E. Sise is a Nephrology, they have specific expertise in Interstitial Nephritis, Chronic Kidney Disease, and Prerenal Azotemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nephrology.

Does Dr. Meghan E. Sise participate in research or clinical trials?

Yes. Dr. Meghan E. Sise has published 162 articles and abstracts on conditions like Interstitial Nephritis. You can view a list of Dr. Meghan E. Sise's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Meghan E. Sise accept my insurance?

Dr. Meghan E. Sise accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-726-5050 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sise's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 23 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile